Kirk HartleyFeb 11, 20141 min readEven the Economist is Following Genetic TherapiesChange is happening. Even the ever stodgy Economist is paying attention to and writing optimistically about genetic therapies. #Science
Change is happening. Even the ever stodgy Economist is paying attention to and writing optimistically about genetic therapies. #Science
Due Process in a Trial About 22 Ovarian Cancers - J&J's Cert Petition for Ingham Talc VerdictAs it said it would do, J&J filed a cert petition seeking review of the Ingham verdict against it and others. The verdict involved 22 ovarian cancer claims grouped together for trial. It will be inter